CN / EN
联系我们
KYKJT
LL-37 (37-1)

LL-37 (37-1)

  • 80%,90%,95%,98%,99%
  • 询价

LL-37 (37-1) 是 LL-37 (HY-P1222) 的反向序列,其生物活性与 LL-37 高度相似。LL-37 (37-1) 具有杀菌功能,是一种免疫系统宿主防御肽。LL-37 (37-1) 可通过与双链 RNA (dsRNA) 相互作用,抑制双链 RNA 诱导的胸腺基质淋巴细胞生成素、CCL5/RANTES、CXCL10/IP-10 和 CXCL8/IL-8 的产生,并上调 CXCL8 的表达。LL-37 (37-1) 可用于银屑病、特应性皮炎的相关研究。

产品信息

产品名称LL-37 (37-1)
产品描述LL-37 (37-1) is the reverse sequence of LL-37 (HY-P1222), with biological activity highly similar to that of LL-37. LL-37 (37-1) has bactericidal function and is a host defense peptide of the immune system. LL-37 (37-1) can interact with double-stranded RNA (dsRNA) to inhibit double-stranded RNA-induced production of thymic stromal lymphopoietin, CCL5/RANTES, CXCL10/IP-10, and CXCL8/IL-8, and upregulate the expression of CXCL8. LL-37 (37-1) can be used in research on psoriasis and atopic dermatitis.
生物活性LL-37 (37-1) is the reverse sequence of LL-37 (HY-P1222), with biological activity highly similar to that of LL-37. LL-37 (37-1) has bactericidal activity and acts as an immune system host defense peptide. LL-37 (37-1) inhibits double-stranded RNA (dsRNA)-induced production of thymic stromal lymphopoietin, CCL5/RANTES, CXCL10/IP-10 and CXCL8/IL-8, and upregulates the expression of CXCL8 via interaction with dsRNA. LL-37 (37-1) can be used in research related to psoriasis and atopic dermatitis.
分子式C205H340N60O53
CAS号2022972-70-7
序列Ser-Glu-Thr-Arg-Pro-Val-Leu-Asn-Arg-Leu-Phe-Asp-Lys-Ile-Arg-Gln-Val-Ile-Arg-Lys-Phe-Glu-Lys-Gly-Ile-Lys-Glu-Lys-Ser-Lys-Arg-Phe-Phe-Asp-Gly-Leu-Leu
序列缩写SETRPVLNRLFDKIRQVIRKFEKGIKEKSKRFFDGLL
储存方式Please store the product under the recommended conditions in the Certificate of Analysis.
上一个:
Daptomycin
下一个:
LL-37, human
置顶